PTGS2 and colorectal cancer: A recent study by Kosumin et al. [30] showed the interactive role of BRAF mutation status and COX-2 overexpression in the prognostication of colorectal cancer patients, suggesting that upregulation ofMAP kinase pathway mediates overexpression of COX-2 in BRAFV600E tumor cells.